The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
State of the art in PEGylation: The great versatility achieved after forty years of research
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Rosenberg, S. A., Lotze, M. T., Muul, L. M., Chang, A. E., Avis, F. P., Leitman, S., Linehan, W. M., Robertson, C. N., Lee, R. E., Rubin, J. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161501 · Cited by 2,735
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Chemistry for peptide and protein PEGylation
Roberts, M. J., Bentley, M. D., & Harris, J. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00022-4 · Cited by 1,604
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
Expanding the Genetic Code of Escherichia coli
Wang, L., Brock, A., Herberich, B., & Schultz, P. G. (2001) · Science · doi:10.1126/science.1060077 · Cited by 1,499
Poly(ethylene glycol) chemistry : biotechnical and biomedical applications
Harris, J. M. (1992) · Plenum Press eBooks · Cited by 1,426
Saito, G., Swanson, J. A., & Lee, K.-D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00179-5 · Cited by 1,407
Abuchowski, A., van Es, T., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
Abuchowski, A., McCoy, J. R., Palczuk, N. C., van Es, T., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,274
Transglutaminases: multifunctional cross‐linking enzymes that stabilize tissues
Greenberg, C. S., Birckbichler, P. J., & Rice, R. H. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.15.1683845 · Cited by 985
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates
Caliceti, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00108-x · Cited by 947
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
Trainer, P. J., Drake, W. M., Katznelson, L., Freda, P. U., Herman-Bonert, V., van der Lely, A. J., Dimaraki, E. V., Stewart, P. M., Friend, K. E., Vance, M. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004203421604 · Cited by 879
Leonard, J. P., Sherman, M. L., Fisher, G. L., Buchanan, L. J., Larsen, G., Atkins, M. B., Sosman, J. A., Dutcher, J. P., Vogelzang, N. J., & Ryan, J. L. (1997) · PubMed · Cited by 820
Solid lipid nanoparticles as a drug delivery system for peptides and proteins☆
ALMEIDA, A., & SOUTO, E. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.007 · Cited by 814
Yamaoka, T., Tabata, Y., & Ikada, Y. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830432 · Cited by 748
Sortases and the Art of Anchoring Proteins to the Envelopes of Gram-Positive Bacteria
Marraffini, L. A., DeDent, A. C., & Schneewind, O. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.70.1.192-221.2006 · Cited by 686
Greco, F., & Vicent, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.006 · Cited by 652
Pyrrolysine Encoded by UAG in Archaea: Charging of a UAG-Decoding Specialized tRNA
Srinivasan, G., James, C. M., & Krzycki, J. A. (2002) · Science · doi:10.1126/science.1069588 · Cited by 639
Polymer–drug conjugation, recent achievements and general strategies
Pasut, G., & Veronese, F. M. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.008 · Cited by 616
Self-citationTon-That, H., Liu, G., Mazmanian, S. K., Faull, K. F., & Schneewind, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12424 · Cited by 567
PEGylated antibodies and antibody fragments for improved therapy: a review
Chapman, A. P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00026-1 · Cited by 556
Sortagging: a versatile method for protein labeling
Popp, M. W., Antos, J. M., Grotenbreg, G. M., Spooner, E., & Ploegh, H. L. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.31 · Cited by 541
Enhancement of therapeutic protein in vivo activities through glycoengineering
Elliott, S., Lorenzini, T., Asher, S., Aoki, K., Brankow, D., Buck, L., Busse, L., Chang, D., Fuller, J., Grant, J., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt799 · Cited by 510
Chemistry of Protein Conjugation and Cross Linking
Wong, S. S. (1991) · Medical Entomology and Zoology · Cited by 490
Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates
Alley, S. C., Benjamin, D. R., Jeffrey, S. C., Okeley, N. M., Meyer, D. L., Sanderson, R. J., & Senter, P. D. (2008) · Bioconjugate Chemistry · doi:10.1021/bc7004329 · Cited by 479
Tunable Degradation of Maleimide–Thiol Adducts in Reducing Environments
Baldwin, A. D., & Kiick, K. L. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200148v · Cited by 470
PEG conjugates in clinical development or use as anticancer agents: An overview
Pasut, G., & Veronese, F. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.02.010 · Cited by 457
Self-citationPolyoxazoline: Chemistry, Properties, and Applications in Drug Delivery
Viegas, T. X., Bentley, M. D., Harris, J. M., Fang, Z., Yoon, K., Dizman, B., Weimer, R., Mero, A., Pasut, G., & Veronese, F. M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200049d · Cited by 432
Self-citationWang, Y.-S., Youngster, S., Grace, M., Bausch, J., Bordens, R., & Wyss, D. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00027-3 · Cited by 420
Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products
Fruijtier-Pölloth, C. (2005) · Toxicology · doi:10.1016/j.tox.2005.06.001 · Cited by 407
Martins, S., Sarmento, B. F. C. C., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 399
PEG-modified biopharmaceuticals
Bailon, P., & Won, C.-Y. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802650568 · Cited by 366
Matrices and scaffolds for protein delivery in tissue engineering
Tessmar, J. K., & Göpferich, A. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.020 · Cited by 346
Advances in PEGylation of important biotech molecules: delivery aspects
Ryan, S. M., Mantovani, G., Wang, X., Haddleton, D. M., & Brayden, D. J. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.4.371 · Cited by 323
Pegaspargase: a review of clinical studies
Graham, M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00110-8 · Cited by 322
Mono-N-terminal poly(ethylene glycol)–protein conjugates
Kinstler, O., Molineux, G., Treuheit, M., Ladd, D., & Gegg, C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00023-6 · Cited by 306
Modulation of interaction forces between bilayers exposing short-chained ethylene oxide headgroups
Kuhl, T. L., Leckband, D. E., Lasic, D. D., & Israelachvili, J. N. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80938-5 · Cited by 304
The different faces of poly(ethylene glycol)
Israelachvili, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8378 · Cited by 303
PEG-uricase in the management of treatment-resistant gout and hyperuricemia
Sherman, M. R., Saifer, M. G. P., & Perez-Ruiz, F. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.011 · Cited by 291
Veronese, F. M., Schiavon, O., Pasut, G., Mendichi, R., Andersson, L., Tsirk, A., Ford, J., Wu, G., Kneller, S., Davies, J., et al. (2005) · Bioconjugate Chemistry · doi:10.1021/bc040241m · Cited by 282
Self-citationBendele, A. M., Seely, J., Richey, C., Sennello, G., & Shopp, G. M. (1998) · Toxicological Sciences · doi:10.1006/toxs.1997.2396 · Cited by 279
Site-specific PEGylation of proteins containing unnatural amino acids
Deiters, A., Cropp, T. A., Summerer, D., Mukherji, M., & Schultz, P. G. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.059 · Cited by 262
Site-specific PEGylation of native disulfide bonds in therapeutic proteins
Shaunak, S., Godwin, A., Choi, J.-W., Balan, S., Pedone, E., Vijayarangam, D., Heidelberger, S., Teo, I., Zloh, M., & Brocchini, S. (2006) · Nature Chemical Biology · doi:10.1038/nchembio786 · Cited by 261
A Branched Monomethoxypoly(ethylene glycol) for Protein Modification
Monfardini, C., Schiavon, O., Caliceti, P., Morpurgo, M., Harris, J. M., & Veronese, F. M. (1995) · Bioconjugate Chemistry · doi:10.1021/bc00031a006 · Cited by 257
Self-citationSite-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase
Fontana, A., Spolaore, B., Mero, A., & Veronese, F. M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.015 · Cited by 249
Self-citationPEGylated Protein Drugs: Basic Science and Clinical Applications
(2009) · doi:10.1007/978-3-7643-8679-5 · Cited by 241
Self-citationUse of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C
Rajender Reddy, K., Modi, M. W., & Pedder, S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00028-5 · Cited by 241
Effects of PEG conjugation on insulin properties
Hinds, K. D., & Kim, S. W. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00025-x · Cited by 240
Characterization and Stability of N-terminally PEGylated rhG-CSF
Kinstler, O. B., Brems, D. N., Lauren, S. L., Paige, A. G., Hamburger, J. B., & Treuheit, M. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016042220817 · Cited by 239
Introduction and overview of peptide and protein pegylation
(2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00020-0 · Cited by 235
Mero, A., Pasut, G., Via, L. D., Fijten, M. W. M., Schubert, U. S., Hoogenboom, R., & Veronese, F. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.010 · Cited by 226
Self-citationLevy, Y., Hershfield, M. S., Fernandez-Mejia, C., Polmar, S. H., Scudiery, D., Berger, M., & Sorensen, R. U. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80271-3 · Cited by 215
Pinto Reis, C., Neufeld, R. J., Ribeiro, A. J., & Veiga, F. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.04.009 · Cited by 215
Basu, A., Yang, K., Wang, M., Liu, S., Chintala, R., Palm, T., Zhao, H., Peng, P., Wu, D., Zhang, Z., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050322y · Cited by 213
Improving the therapeutic efficacy of peptides and proteins: A role for polysialic acids
Gregoriadis, G., Jain, S., Papaioannou, I., & Laing, P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.007 · Cited by 202
Optimized clinical performance of growth hormone with an expanded genetic code
Cho, H., Daniel, T., Buechler, Y. J., Litzinger, D. C., Maio, Z., Putnam, A.-M. H., Kraynov, V. S., Sim, B.-C., Bussell, S., Javahishvili, T., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100387108 · Cited by 199
Direct Measurement of Polyethylene Glycol Induced Depletion Attraction between Lipid Bilayers
Kuhl, T., Guo, Y., Alderfer, J. L., Berman, A. D., Leckband, D., Israelachvili, J., & Hui, S. W. (1996) · Langmuir · doi:10.1021/la950802l · Cited by 194
Macdougall, I. C. (2005) · PubMed · Cited by 192
Enzymatic procedure for site-specific pegylation of proteins
Sato, H. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00024-8 · Cited by 187
Disulfide bridge based PEGylation of proteins
Brocchini, S., Godwin, A., Balan, S., Choi, J.-W., Zloh, M., & Shaunak, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.014 · Cited by 186
Negrier, C., Knobe, K., Tiede, A., Giangrande, P., & Møss, J. (2011) · Blood · doi:10.1182/blood-2011-02-335596 · Cited by 184
Sortase-catalyzed transformations that improve the properties of cytokines
Popp, M. W., Dougan, S. K., Chuang, T.-Y., Spooner, E., & Ploegh, H. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016863108 · Cited by 183
Site-Specific Protein Modification Using a Ketone Handle
Cornish, V. W., Hahn, K. M., & Schultz, P. G. (1996) · Journal of the American Chemical Society · doi:10.1021/ja961216x · Cited by 179
Fee, C. J., & Van Alstine, J. M. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049843w · Cited by 174
GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli
DeFrees, S., Wang, Z.-G., Xing, R., Scott, A. E., Wang, J., Zopf, D., Gouty, D. L., Sjoberg, E. R., Panneerselvam, K., Brinkman-Van der Linden, E. C. M., et al. (2006) · Glycobiology · doi:10.1093/glycob/cwl004 · Cited by 174
Site-Specific PEGylation of Protein Disulfide Bonds Using a Three-Carbon Bridge
Balan, S., Choi, J.-W., Godwin, A., Teo, I., Laborde, C. M., Heidelberger, S., Zloh, M., Shaunak, S., & Brocchini, S. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0601471 · Cited by 172
Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides
Dharap, S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00209-8 · Cited by 172
Antitumoral activity of PEG–gemcitabine prodrugs targeted by folic acid
Pasut, G., Canal, F., Dalla Via, L., Arpicco, S., Veronese, F. M., & Schiavon, O. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.02.002 · Cited by 160
Self-citationSite‐Specific Protein Modification on Living Cells Catalyzed by Sortase
Tanaka, T., Yamamoto, T., Tsukiji, S., & Nagamune, T. (2008) · ChemBioChem · doi:10.1002/cbic.200700614 · Cited by 156
Anti-cancer PEG-enzymes: 30 years old, but still a current approach
Pasut, G., Sergi, M., & Veronese, F. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.018 · Cited by 152
Self-citationØstergaard, H., Bjelke, J. R., Hansen, L., Petersen, L. C., Pedersen, A. A., Elm, T., Møller, F., Hermit, M. B., Holm, P. K., Krogh, T. N., et al. (2011) · Blood · doi:10.1182/blood-2011-02-336172 · Cited by 145
Pyrrolysine and Selenocysteine Use Dissimilar Decoding Strategies
Zhang, Y., Baranov, P. V., Atkins, J. F., & Gladyshev, V. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501458200 · Cited by 135
Phase I study of recombinant human tumor necrosis factor
Kimura, K., Taguchi, T., Urushizaki, I., Ohno, R., Abe, O., FURUE, H., Hattori, T., Ichihashi, H., Inoguchi, K., Majima, H., et al. (1987) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00570490 · Cited by 133
Fate of Water‐Soluble Polymers Administered via Different Routes
Yamaoka, T., Tabata, Y., & Ikada, Y. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840316 · Cited by 130
Identification of the Major Positional Isomer of Pegylated Interferon Alpha-2b
Wang, Y.-S., Youngster, S. K., Bausch, J. N., et al. (2000) · Biochemistry · doi:10.1021/bi000617t · Cited by 130
Dendritic Poly(ethylene glycol) Bearing Paclitaxel and Alendronate for Targeting Bone Neoplasms
Clementi, C., Miller, K., Mero, A., Satchi‐Fainaro, R., & Pasut, G. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2001445 · Cited by 124
Self-citationLuckham, P. F., & Klein, J. E. (1985) · Macromolecules · doi:10.1021/ma00146a025 · Cited by 123
Dhalluin, C., Ross, A., Leuthold, L. A., Foser, S., Gsell, B., Müller, F., & Senn, H. (2005) · Bioconjugate Chemistry · doi:10.1021/bc049781+ · Cited by 114
Greenwald, R. B., Choe, Y. H., Conover, C. D., Shum, K. L., Wu, D., & Royzen, M. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990498j · Cited by 107
Synthesis and Characterization of Poly(ethylene glycol)−Insulin Conjugates
Hinds, K. D., Koh, J. J., Joss, L., Liu, F., Baudyš, M., & Kim, S. W. (2000) · Bioconjugate Chemistry · doi:10.1021/bc9901189 · Cited by 103
Fc-Based Cytokines: Prospects for Engineering Superior Therapeutics
Jazayeri, J. A., & Carroll, G. J. (2008) · BioDrugs · doi:10.2165/00063030-200822010-00002 · Cited by 103
Lipid-polyethylene glycol interactions: I. Induction of fusion between liposomes
Boni, L. T., Stewart, T. P., Alderfer, J. L., & Hui, S. W. (1981) · The Journal of Membrane Biology · doi:10.1007/bf01870200 · Cited by 98
PEG–Ara-C conjugates for controlled release
Schiavon, O., Pasut, G., Moro, S., Orsolini, P., Guiotto, A., & Veronese, F. M. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2003.10.005 · Cited by 95
Self-citationLongstaff, D. G., Larue, R. C., Faust, J. E., Mahapatra, A., Zhang, L., Green‐Church, K. B., & Krzycki, J. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610294104 · Cited by 90
Site-Specific Pegylation of G-CSF by Reversible Denaturation
Veronese, F. M., Mero, A., Caboi, F., Sergi, M., Marongiu, C., & Pasut, G. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070123+ · Cited by 88
Self-citationPEG-epirubicin Conjugates with High Drug Loading
Pasut, G., Scaramuzza, S., Schiavon, O., Mendichi, R., & Veronese, F. M. (2005) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911505053377 · Cited by 87
Self-citationPeptide and protein PEGylation III: advances in chemistry and clinical applications
Veronese, F. M., & Harris, J. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.003 · Cited by 87
Self-citationRelevance of folic acid/polymer ratio in targeted PEG–epirubicin conjugates
Canal, F., Vicent, M. J., Pasut, G., & Schiavon, O. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.05.027 · Cited by 82
Self-citationGreenwald, R. B., Yang, K., Zhao, H., et al. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025652m · Cited by 79
Pegylation for improving the effectiveness of therapeutic biomolecules
Pasut, G., & Veronese, F. M. (2009) · Drugs of today · doi:10.1358/dot.2009.45.9.1416421 · Cited by 78
Self-citationTsubery, H., Mironchik, M., Fridkin, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405155200 · Cited by 76
Mero, A., Schiavon, M., Veronese, F. M., & Pasut, G. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.04.024 · Cited by 73
Self-citationCysteine 17 of recombinant human granulocyte-colony stimulating factor is partially solvent-exposed
Arakawa, T., Prestrelski, S. J., Narhi, L. O., Boone, T. C., & Kenney, W. C. (1993) · Journal of Protein Chemistry · doi:10.1007/bf01025117 · Cited by 70
Recombinant Protein Hydrazides: Application to Site-Specific Protein PEGylation
Thom, J., Anderson, D., McGregor, J., & Cotton, G. (2011) · Bioconjugate Chemistry · doi:10.1021/bc2001374 · Cited by 70
Lipid-polyethylene glycol interactions: II. Formation of defects in bilayers
Boni, L. T., Stewart, T. P., Alderfer, J. L., & Hui, S. W. (1981) · The Journal of Membrane Biology · doi:10.1007/bf01870201 · Cited by 65
Zhao, H., Yang, K., Martinez, A. D., Basu, A., Chintala, R., Liu, H.-C., Janjua, A., Wang, M., & Filpula, D. R. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050270c · Cited by 63
Delivery technologies for biopharmaceuticals : peptides, proteins, nucleic acids and vaccines
Jørgensen, L., & Nielsen, H. M. (2009) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 58
Generation and biochemical characterization of glycoPEGylated factor VIIa derivatives
Østergaard, H., Bayer, R. J., Kalo, M. S., et al. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-04-0268 · Cited by 58
Young, M. A., Malavalli, A., Winslow, N., Vandegriff, K. D., & Winslow, R. M. (2007) · Translational research · doi:10.1016/j.trsl.2006.09.007 · Cited by 55
Enzymatically catalyzed HES conjugation using microbial transglutaminase: Proof of feasibility
Besheer, A., Hertel, T. C., Kreßler, J., Mäder, K., & Pietzsch, M. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21675 · Cited by 55
PEGylation: Posttranslational bioengineering of protein biotherapeutics
Veronese, F. M., & Pasut, G. (2008) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2009.02.002 · Cited by 54
Self-citationSite-specific protein modifications through pyrroline-carboxy-lysine residues
Ou, W., Uno, T., Chiu, H., Grünewald, J., Cellitti, S. E., Crossgrove, T., Hao, X., Fan, Q., Quinn, L., Patterson, P., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105197108 · Cited by 53
Andersson, L. I., Davies, J., Duncan, R., Ferruti, P., Ford, J., Kneller, S., Mendichi, R., Pasut, G., Schiavon, O., Summerford, C., et al. (2005) · Biomacromolecules · doi:10.1021/bm049381p · Cited by 52
Self-citationCarboxyalkylated Histidine Is a pH-Dependent Product of Pegylation with SC-PEG
Wylie, D. C., Voloch, M., Lee, S., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1013006515587 · Cited by 47
Metzger, F., Sajid, W., Saenger, S., Staudenmaier, C., van der Poel, C., Sobottka, B., Schuler, A., Sawitzky, M., Poirier, R., Tuerck, D., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172189 · Cited by 46
Santucci, L., Mencarelli, A., Renga, B., Pasut, G., Veronese, F. M., Zacheo, A., Germani, A., & Fiorucci, S. (2006) · The FASEB Journal · doi:10.1096/fj.05-4452fje · Cited by 46
Self-citationPEGylation of Human Serum Albumin: Reaction of PEG-Phenyl-Isothiocyanate with Protein
Meng, F., Manjula, B. N., Smith, P. K., & Acharya, S. A. (2008) · Bioconjugate Chemistry · doi:10.1021/bc7003878 · Cited by 44
Polymer−Drug Conjugates for Combination Anticancer Therapy: Investigating the Mechanism of Action
Pasut, G., Greco, F., Mero, A., Mendichi, R., Fante, C., Green, R. J., & Veronese, F. M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900804m · Cited by 44
Self-citationDigilio, G., Barbero, L. M., Bracco, C., Corpillo, D., Esposito, P., Piquet, G., Traversa, S., & Aime, S. (2003) · Journal of the American Chemical Society · doi:10.1021/ja021264j · Cited by 44
A New PEG−β-Alanine Active Derivative for Releasable Protein Conjugation
Pasut, G., Mero, A., Caboi, F., Scaramuzza, S., Sollai, L., & Veronese, F. M. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800281s · Cited by 39
Self-citationD-Ornithine coopts pyrrolysine biosynthesis to make and insert pyrroline-carboxy-lysine
Cellitti, S. E., Ou, W., Chiu, H., Grünewald, J., Jones, D. H., Hao, X., Fan, Q., Quinn, L., Ng, K., Anfora, A., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.586 · Cited by 38
Transitional Vacuole Formation Following a Bolus Infusion of Peg-Hemoglobin in the Rat
Conover, C., Lejeune, L., Linberg, R., Shum, K. L., & Shorr, R. (1996) · Artificial Cells Blood Substitutes and Biotechnology · doi:10.3109/10731199609118885 · Cited by 37
Effect of poly(ethylene glycol) on the calcium-induced fusion of didodecyl phosphate vesicles
Rupert, L. A. M., Engberts, J. B. F. N., & Hoekstra, D. (1988) · Biochemistry · doi:10.1021/bi00421a037 · Cited by 37
Multivalent and Flexible PEG-Nitrilotriacetic Acid Derivatives for Non-covalent Protein Pegylation
Mero, A., Ishino, T., CHAIKEN, I. M., Veronese, F. M., & Pasut, G. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0468-8 · Cited by 35
Self-citationMueller, C., Capelle, M. A. H., Arvinte, T., Seyrek, E., & Borchard, G. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.06.003 · Cited by 31
N-terminal specificity of PEGylation of human bone morphogenetic protein-2 at acidic pH
Hu, J., & Sebald, W. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.043 · Cited by 26
Insulin detemir: A long-acting insulin product
Jones, M. C., & Patel, M. P. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060102 · Cited by 18
Platis, D., & Labrou, N. E. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785132924 · Cited by 13
Certolizumab pegol: a PEGylated anti-tumour necrosis factor alpha biological agent
Nesbitt, A. M., Stephens, S., & Chartash, E. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8679-5_14 · Cited by 9
Cited by
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Polyethylene glycol (PEG): A versatile polymer for pharmaceutical applications
D’souza, A. A., & Shegokar, R. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1182485 · Cited by 1,282
Nichols, J. W., & Bae, Y. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.057 · Cited by 834
Turecek, P. L., Bossard, M. J., Schoetens, F., & Ivens, I. A. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.015 · Cited by 733
Garay, R. P., El-Gewely, R., Armstrong, J. K., Garratty, G., & Richette, P. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.720969 · Cited by 587
Metadata
- Authors
- Pasut, G., & Veronese, F. M.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 161
- Issue
- 2
- Pages
- 461-472
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2084587462
- Cited by
- 720
- References
- 123
- FWCI
- 27.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.